DMRA Galecto, Inc.
Healthcare$25.30+1.77%ClosedMarket Cap: $1.56B
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
0.08
P/S
0.00
EV/EBITDA
2.06
DCF Value
$194.39
FCF Yield
-61.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-122.4%
ROA
-43.9%
ROIC
-46.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-30.8M | $-27.8M | $— | — |
| Q4 null | $0.00 | NaN% | $-201.7M | $-200.7M | $— | — |
| FY null | $0.00 | NaN% | $-210.9M | $-209.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-3.2M | $-3.1M | $— | — |
| Q2 null | $0.00 | NaN% | $-3.4M | $-3.4M | $— | — |
| Q1 null | $0.00 | NaN% | $-2.6M | $-2.5M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-2.7M | $-6.7M | $— | — |
| FY null | $0.00 | -Infinity% | $-16.9M | $-21.4M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-3.8M | $-3.9M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-4.6M | $-5.3M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-5.7M | $-5.5M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-6.0M | $-6.5M | $-5.97 | — |